Seres Therapeutics Statistics
Total Valuation
MCRB has a market cap or net worth of $12.64 million. The enterprise value is $30.89 million.
Important Dates
The last earnings date was Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MCRB has 10.20 million shares outstanding. The number of shares has increased by 10.70% in one year.
| Current Share Class | 10.20M |
| Shares Outstanding | 10.20M |
| Shares Change (YoY) | +10.70% |
| Shares Change (QoQ) | +2.84% |
| Owned by Insiders (%) | 0.51% |
| Owned by Institutions (%) | 10.07% |
| Float | 8.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.95 |
| Forward PS | 1.99 |
| PB Ratio | 0.58 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 14.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 1.67.
| Current Ratio | 1.65 |
| Quick Ratio | 1.56 |
| Debt / Equity | 1.67 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -144.35% and return on invested capital (ROIC) is -44.47%.
| Return on Equity (ROE) | -144.35% |
| Return on Assets (ROA) | -44.85% |
| Return on Invested Capital (ROIC) | -44.47% |
| Return on Capital Employed (ROCE) | -147.12% |
| Weighted Average Cost of Capital (WACC) | 1.92% |
| Revenue Per Employee | $32,197 |
| Profits Per Employee | -$711,409 |
| Employee Count | 66 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.67% in the last 52 weeks. The beta is 0.56, so MCRB's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | -95.67% |
| 50-Day Moving Average | 2.56 |
| 200-Day Moving Average | 6.10 |
| Relative Strength Index (RSI) | 21.40 |
| Average Volume (20 Days) | 93,425 |
Short Selling Information
The latest short interest is 342,237, so 3.36% of the outstanding shares have been sold short.
| Short Interest | 342,237 |
| Short Previous Month | 312,339 |
| Short % of Shares Out | 3.36% |
| Short % of Float | 3.81% |
| Short Ratio (days to cover) | 4.06 |
Income Statement
In the last 12 months, MCRB had revenue of $2.13 million and -$46.95 million in losses. Loss per share was -$4.88.
| Revenue | 2.13M |
| Gross Profit | -38.08M |
| Operating Income | -66.20M |
| Pretax Income | -46.95M |
| Net Income | -46.95M |
| EBITDA | -63.31M |
| EBIT | -66.20M |
| Loss Per Share | -$4.88 |
Full Income Statement Balance Sheet
The company has $17.53 million in cash and $35.77 million in debt, with a net cash position of -$18.24 million or -$1.79 per share.
| Cash & Cash Equivalents | 17.53M |
| Total Debt | 35.77M |
| Net Cash | -18.24M |
| Net Cash Per Share | -$1.79 |
| Equity (Book Value) | 21.36M |
| Book Value Per Share | 2.13 |
| Working Capital | 13.53M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$63.94 million and capital expenditures -$29,000, giving a free cash flow of -$63.97 million.
| Operating Cash Flow | -63.94M |
| Capital Expenditures | -29,000 |
| Depreciation & Amortization | 2.89M |
| Net Borrowing | n/a |
| Free Cash Flow | -63.97M |
| FCF Per Share | -$6.27 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | -3,115.15% |
| Pretax Margin | -2,209.55% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MCRB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -10.70% |
| Shareholder Yield | -10.70% |
| Earnings Yield | -393.16% |
| FCF Yield | -506.02% |
Analyst Forecast
The average price target for MCRB is $17.00, which is 1,270.97% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.00 |
| Price Target Difference | 1,270.97% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | -29.75% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on April 22, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Apr 22, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
MCRB has an Altman Z-Score of -23.07 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -23.07 |
| Piotroski F-Score | 2 |